MetaCap

Who Owns ACADIA Pharmaceuticals Stock?

NASDAQ: ACADHealth CareBiotechnology: Pharmaceutical PreparationsUSD

17.11-0.48 (-2.73%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
98.25%
Institutional holders
471
  • Institutions 98.3%
  • Insiders 0.7%
  • Public and other 1.0%

Who owns ACADIA Pharmaceuticals stock?

Institutional investors own about 98.3% of ACADIA Pharmaceuticals's shares, spread across 471 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.73% of ACAD.

The largest institutional holders are Baker Bros. Advisors, LP (24.83%), Blackrock Inc. (13.03%) and Vanguard Portfolio Management LLC (5.11%). Together, the top 10 institutions control 61.9% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their ACAD positions and 3 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of ACAD

ACADIA Pharmaceuticals top institutional holders
InstitutionShares% HeldChange
Baker Bros. Advisors, LP42.91M24.83%+0.0%
Blackrock Inc.22.52M13.03%+4.5%
Vanguard Portfolio Management LLC8.84M5.11%+1.9%
State Street Corporation7.65M4.43%-15.7%
RTW Investments LP7.14M4.13%0.0%
Vanguard Capital Management LLC5.76M3.33%+1.8%
Geode Capital Management, LLC3.37M1.95%+0.4%
Dimensional Fund Advisors LP3.37M1.95%-8.9%
Palo Alto Investors Lp2.86M1.66%-0.3%
Goldman Sachs Group Inc2.58M1.49%+65.6%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of ACAD

ACADIA Pharmaceuticals top fund holders
FundShares% Held
iShares Trust-iShares Core S&P Small-Cap ETF7.69M4.45%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund4.07M2.36%
iShares Trust-iShares Russell 2000 ETF3.33M1.93%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.95M1.71%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF2.47M1.43%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund1.70M0.98%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.46M0.84%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund1.41M0.82%
iShares Trust-iShares Biotechnology ETF1.33M0.77%
iShares Trust-iShares Russell 2000 Growth ETF1.21M0.70%

Frequently asked questions

Who is the largest shareholder of ACADIA Pharmaceuticals?

Baker Bros. Advisors, LP is the largest institutional shareholder of ACAD, owning 24.83% of shares outstanding (42.91M shares) as of its latest 13F filing.

What percentage of ACADIA Pharmaceuticals is owned by institutions?

Institutions own about 98.3% of ACAD shares and 99.0% of the public float.

How much of ACADIA Pharmaceuticals do insiders own?

Insiders, such as officers and directors, own about 0.73% of ACAD shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related